Loading Complete
Sandeep Wontakal

Sandeep Wontakal, MD, PhD

Pathology

Highlights

Languages

  • Kannada
  • English

Gender

Male

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Sandeep Wontakal

Professional Titles

Director of Clinical Pathology at JHBMC

Primary Academic Title

Assistant Professor of Pathology

Background

Dr. Sandeep Wontakal is an Assistant Professor of Pathology and Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the Director of Clinical Pathology at JHBMC, overseeing the clinical core laboratory and blood bank. In addition, he is a member of the JH Genomics and the DNA Diagnostics Laboratory, where he reviews germline genetic and genomic testing. Sandeep has clinical expertise in genomic testing of rare inherited diseases.

Sandeep grew up in New York City and is a proud product of the NYC public school system. He received his B.A. in Molecular Biology & Biochemistry with minors in Mathematics and Philosophy from Rutgers University. He subsequently enrolled in the M.D./Ph.D. program at the Albert Einstein College of Medicine, where his Ph.D. thesis focused on understanding transcriptional regulation of erythropoiesis. He obtained clinical training in Clinical Pathology and subspecialization training in Molecular Genetic Pathology at New York Presbyterian Hospital - Columbia University Irving Medical Center, where he also served as Chief Resident. After completing his clinical training, he pursued post-doctoral training working with C. elegans to model and better understand the molecular consequences of rare variants identified in patients. His research group continues to utilize model organisms to better understand the functional consequences of rare human variants.

Additional Academic Titles

Assistant Professor of Genetic Medicine

Contact for Research Inquiries

720 Rutland Ave

Ross Building, Room 632B

Baltimore, MD 21205

Phone: (410) 614-8138

Research Interests

Genetics, Genomics, Rare Disease, Model Organisms

Research Summary

The work in our group focuses on searching for novel disease genes, establishing the pathogenicity of these genes, and understanding the in vivo consequences of their genetic alteration. Our basic working hypothesis is that deleterious variants in multiple components (i.e., genes) of a given genetic pathway could give rise to similar diseases. Therefore, knowing the components of a pathway may allow one to identify novel variants in genes previously not associated with disease. Model organisms, including the roundworm, C. elegans, have served as powerful systems to dissect and identify components of genetic pathways.  We strive to merge human genetics with model organism genetics such that findings in one, drive discovery in the other.

Selected Publications

  • Dharmadhikari AV, Abad MA, Khan S, Maroofian R, Sands TT, Ullah F, Samejima I, Wear MA, Moore KE, Kondakova E, Mitina N, Schaub T, Lee GK, Umandap CH, Berger SM, Iglesias AD, Popp B, Jamra RA, Gabriel H, Rentas S, Rippert AL, Izumi K, Conlin LK, Koboldt DC, Mosher TM, Hickey SE, Albert DVF, Norwood H, Lewanda AF, Dai H, Liu P, Mitani T, Marafi D, Pehlivan D, Posey JE, Lippa N, Vena N, Heinzen EL, Goldstein DB, Mignot C, de Sainte Agathe JM, Al-Sannaa NA, Zamani M, Sadeghian S, Azizimalamiri R, Seifia T, Zaki MS, Abdel-Salam GMH, Abdel-Hamid M, Alabdi L, Alkuraya FS, Dawoud H, Lofty A, Bauer P, Zifarelli G, Afzal E, Zafar F, Efthymiou S, Gossett D, Towne MC, Yeneabat R, Wontakal SN, Aggarwal VS, Rosenfeld JA, Tarabykin V, Ohta S, Lupski JR, Houlden H, Earnshaw WC, Davis EE, Jeyaprakash AA, Liao J. RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS. medRxiv [Preprint]. 2024 Jan 9:2024.01.09.23300329. doi: 10.1101/2024.01.09.23300329. PMID: 38260255
  • Wontakal SN, Britto M, Zhang H, Han Y, Gao C, Tannenbaum S, Durham BH, Lee MT, An X, Mishima M. RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease. Blood. 2022 Mar 3;139(9):1413-1418. doi: 10.1182/blood.2021012334. PMID: 34818416
  • Wontakal SN, Bortz RH 3rd, Lin WW, Gendlina I, Fox AS, Hod EA, Chandran K, Prystowsky MB, Weiss LM, Spitalnik SL. Approaching the Interpretation of Discordances in SARS-CoV-2 Testing. Open Forum Infect Dis. 2021 Mar 23;8(7):ofab144. doi: 10.1093/ofid/ofab144. PMID: 34316498
  • O'Donnell MR, Grinsztejn B, Cummings MJ, Justman JE, Lamb MR, Eckhardt CM, Philip NM, Cheung YK, Gupta V, João E, Pilotto JH, Diniz MP, Cardoso SW, Abrams D, Rajagopalan KN, Borden SE, Wolf A, Sidi LC, Vizzoni A, Veloso VG, Bitan ZC, Scotto DE, Meyer BJ, Jacobson SD, Kantor A, Mishra N, Chauhan LV, Stone EF, Dei Zotti F, La Carpia F, Hudson KE, Ferrara SA, Schwartz J, Stotler BA, Lin WW, Wontakal SN, Shaz B, Briese T, Hod EA, Spitalnik SL, Eisenberger A, Lipkin WI. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest. 2021 Jul 1;131(13):e150646. doi: 10.1172/JCI150646. PMID: 33974559
  • Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray J, Idzikowski E, Stelitano D, Bovier FT, Davis-Porada J, Matsumoto R, Poon MML, Chait M, Mathieu C, Horvat B, Decimo D, Hudson KE, Zotti FD, Bitan ZC, La Carpia F, Ferrara SA, Mace E, Milner J, Moscona A, Hod E, Porotto M, Farber DL. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol. 2021 Jan;22(1):25-31. doi: 10.1038/s41590-020-00826-9. Epub 2020 Nov 5. PMID: 33154590

Honors

  • Shaffer-Wilk-Miller Fellow in Laboratory Medicine, Shaffer Wilk Miller, 7/1/13
  • Louis and Rachel Rudin Scholar, Louis and Rachel Rudin Foundation, 1/1/10

Graduate Program Affiliations

Human Genetics and Genomics

XDBio

Memberships

  • American Society of Human Genetics
  • Genetics Society of America

Locations

  1. Johns Hopkins Bayview Medical Center
    • 4940 Eastern Avenue, Baltimore, MD 21224

    Expertise

    Education

    New York-Presbyterian Columbia

    Fellowship, Pathology, 2018

    New York-Presbyterian Columbia

    Residency, Pathology Laboratory Medicine, 2017

    Albert Einstein College of Medicine

    Graduate School, Cell Biology, PhD, 2013

    Albert Einstein College of Medicine

    Medical Education, MD, 2013

    Board Certifications

    Molecular Genetic Pathology

    American Board of Pathology, 2019

    Clinical Pathology

    American Board of Pathology, 2018

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)